Candidate Agreement definition

Candidate Agreement means the set of terms that students must agree to as part of their Examination registration;
Sample 1Sample 2Sample 3
Candidate Agreement means an agreement between the University and another research institute or university for the joint supervision of a Degree.
Sample 1Sample 2
Candidate Agreement means the mandatory set of terms that govern a Candidate’s conduct with respect to an Examination;
Sample 1

Examples of Candidate Agreement in a sentence

  • By signing below, the Minor Certification Candidate and Parent/Guardian acknowledge and agree that You are bound by the terms and conditions of the Citrix Certification Program Candidate Agreement, and consent that Citrix may use Your personal information as stated in the Agreement.

  • In addition to any other rights and remedies provided by law or this Candidate Agreement, CFA Institute hereby expressly reserves all of its rights and remedies arising out of a breach of this Candidate Agreement and/or any infringement of any CFA Institute trade secret, copyright and/or trademarks.

  • This Temporary Candidate Agreement (‘TCA’) comprises the framework terms and conditions upon which we are willing to provide our Services, which we confirm are at no charge to you, and upon which you shall perform Assignments (‘these Terms’), and consists of TCA - Part 1, which sets out our primary terms, and TCA - Part 2 which contains our standard main terms.

  • For the purposes of this Candidate Agreement, the candidate’s immediate family is defined as only the candidate’s parent, grandparent, sibling, spouse/domestic partner, or child.

  • The laws of the Commonwealth of Virginia, USA govern this Candidate Agreement.

  • As a candidate in the CFA Program, you must abide by the CFA Program Candidate Agreement, all testing policies and rules, CFA Institute governing documents including the Bylaws, the Code of Ethics, Standards of Professional Conduct, and Rules of Procedure, as amended from time to time.

  • You understand CFA Institute has the authority to void your exam result, and reject, suspend, or terminate your candidacy at any time for your failure to comply with the Candidate Agreement.

  • By registering for the CFA Program, you understand, accept, and agree to comply with the CFA Program Candidate Agreement, as amended from time to time.

  • All individuals interested in the Qualified/ Certified and Validated SUT designations are subject to submitting this Candidate Agreement per completed SUT credential.

  • Full details on the implementation of the doctoral guidance are provided in the QAS (Annex 8) and the Doctoral Candidate Agreement (Annex 2).

Related to Candidate Agreement

  • Collaboration Agreement has the meaning set forth in the Recitals.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • CMPPA Agreement means the CMPPA Agreement between the SSA and CHHS.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Development Plan has the meaning set forth in Section 3.2.

  • Development Schedule shall have the meaning set forth in Section 1.1.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Development Agreement has the meaning set forth in the Recitals.

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Collaborative agreement means a voluntary, written, or electronic arrangement between one

  • DMF means any drug master file filed with the FDA, and any equivalent filing in other countries or regulatory jurisdictions.

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Clinical Supply Agreement shall have the meaning set forth in Section 7.2.

  • Joint Development Agreement has the meaning provided in Section 5.3.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Pharmacovigilance Agreement has the meaning set forth in Section 4.3.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Quality Agreement has the meaning set forth in Section 9.6.

  • Tri-Party Agreement shall have the meaning set forth in Section 6.4 hereof.

  • Mediation agreement means a written agreement between the parties to a mediation meeting.

  • Development Agreements means all development, utility or similar agreements included in the Permitted Encumbrances.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.